- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 193 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 155 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 181 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 209 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 192 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 251 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 892 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 231 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07.25 | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 226 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05.25 | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 338 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05.25 | Simris Group AB: Simris Group Interim Report January-march 2025 | 407 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02.25 | Simris Group AB: Simris Group Year-end Report January-december 2024 | 266 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,679 | +9,52 % | Beyond Meat's Odds of Beating Earnings Just Hit 21% -- Is This the Quarter the Stock Finally Breaks? | ||
| OATLY GROUP | 10,500 | -1,87 % | Nach über 30 Jahren: Erstmals Gewinn bei Haferdrink-Hersteller Oatly | ||
| CONAGRA BRANDS | 15,672 | -3,40 % | Is Ultra-High-Yield Conagra Brands a Buy, Sell, or Hold in 2026? | ||
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 210,00 | 0,00 % | Wingstop Restaurants Inc.: Wingstop Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results | Record 493 Net New Openings in 2025, 19.2% Unit Growth
Achieves 12.1% System-wide Sales Growth for Fiscal Year 2025
Introduces 2026 Guidance
DALLAS, Feb. 18, 2026... ► Artikel lesen | |
| WH GROUP | 1,130 | +1,80 % | WH GROUP (00288): REMINDER LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE UPDATED ARRANGEMENT OF ELECTRONIC DISSEMINATION ... | ||
| MHP | 6,950 | +1,46 % | Ukraine's MHP to buy back $223.7 mln of outstanding 2026 notes on Feb 18 | ||
| JACK IN THE BOX | 14,500 | -2,03 % | Jack in the Box launches matcha: The matcha line includes a latte and a shake | ||
| ELSE NUTRITION | 0,049 | +1,89 % | Else Nutrition Holdings Inc.: Else Nutrition Announces Results from Annual General Meeting of Shareholders | VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general... ► Artikel lesen | |
| BIOGAIA | 10,090 | +0,10 % | Probiotikahersteller BioGaia wächst weiter | ||
| J&J SNACK FOODS | 70,50 | -2,76 % | J & J Snack Foods Corp.: J & J Snack Foods Reports Fiscal 2026 First Quarter Results | MOUNT LAUREL, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) today reported financial results for the first quarter ended December 27, 2025. First QuarterActuals$... ► Artikel lesen | |
| PP LONDON SUMATRA INDONESIA | 0,050 | +1,01 % | XFRA NEW INSTRUMENTS AVAILABLE ON 08.12.2025 | The following instruments on XETRA do have their first trading 08.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.12.2025
Aktien
1 KYG4600C1107 Hope Life International... ► Artikel lesen | |
| CAVA GROUP | 84,29 | +24,23 % | Aktien New York Ausblick: Erholung dürfte weitergehen - KI-Champ Nvidia im Fokus | NEW YORK (dpa-AFX) - Die US-Börsen dürften zur Wochenmitte ihre Erholungsgewinne vom Vortag leicht ausbauen. Es herrscht ein wenig Erleichterung, denn zum Thema Zölle gab es am Vorabend anlässlich... ► Artikel lesen | |
| NESTLE | 90,46 | -0,39 % | Buy or Goodbye?: Nestle, Bayer, Novo Nordisk und Ryanair - Die Analystenstimmen des Tages | © Foto: Jean-Christophe Bott - dpaNestle, Bayer, Novo Nordisk und Ryanair: Die wichtigsten Analysten-Updates im Überblick.JPMorgan stuft Nestle auf "Neutral" Die US-Bank JPMorgan hat die Einstufung... ► Artikel lesen | |
| SUEDZUCKER | 9,820 | +0,51 % | Börse am Morgen: Bayer, Ottobock, Südzucker, Gold, KI-Industrie Marktbericht | Die Ergebnisse der ZEW-Befragungsrunde im Februar zeigen eine Stabilisierung der kräftigen Stimmungsaufhellung unter Finanzmarktexperten seit Jahresstart an. Die Konjunkturerwartungen für Deutschland... ► Artikel lesen |
SIMRIS GROUP AB gehört der Branche Nahrungsmittel/Agrar an. Mit einer aktuellen Kursveränderung von +0,000 (+15,38 %) liegt der Kurs bei 0,003 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.